NCT07072923

Brief Summary

Lower extremity bone infections, such as osteomyelitis, often occur after bone fractures, surgery, or when prosthetic joints or hardware become infected. Treatment usually includes antibiotics, chosen based on the infection's specifics. Options include intravenous (IV) or oral antibiotics, and sometimes local treatment with antibiotic-loaded beads placed directly at the infection site. Traditionally, these beads are made of non-absorbable materials, requiring a second surgery to remove them. However, a newer approach uses absorbable calcium sulfate beads, which can deliver higher antibiotic doses and don't need removal. This study will compare the use of IV and/or antibiotics in combination with absorbable antibiotic calcium sulfate beads with IV and/or oral antibiotics without absorbable beads, which serves as the current standard of care.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
14mo left

Started Sep 2025

Typical duration for phase_4

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Sep 2025Sep 2027

First Submitted

Initial submission to the registry

March 7, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

March 7, 2025

Last Update Submit

July 9, 2025

Conditions

Keywords

osteomyelitis, lower extremity, foot, calcium sulfate beads

Outcome Measures

Primary Outcomes (1)

  • End of Therapy - Clinical Failure

    1. Presence of at least one clinical criterium for failure (frank pus adjacent to bone or implant or draining sinus tract), OR 2. phenotypically indistinguishable bacteria isolated from two or more deep-tissue samples or a single closed aspirate or biopsy OR 3. histologic criteria including presence of characteristic inflammatory infiltrate or microorganisms.

    End of Therapy (usually 4-6 weeks)

Study Arms (2)

IV and/or oral antibiotics with local antibiotic loaded calcium sulfate beads

EXPERIMENTAL

These will be patient who will receive active systemic antibiotics plus calcium sulfate beads loaded with antibiotics

Device: Calcium sulfate beads (sham beads)

IV and/or oral antibiotics plus calcium sulfate beads without antibiotics (sham beads)

ACTIVE COMPARATOR

These patients will receive IV and/or oral antibiotics plus sham beads. They will receive antibiotics systemically.

Drug: Antibiotic loaded calcium sulfate beads

Interventions

Calcium sulfate beads will be loaded with best available antibiotics based on surgeon/infectious disease specialist determination from the following options (vancomycin, daptomycin, cefazolin, cefepime, tobramycin, amphotericin B, micafungin, and voriconazole).

IV and/or oral antibiotics plus calcium sulfate beads without antibiotics (sham beads)

Calcium sulfate beads will be prepared without added antibiotics and placed during the second surgery.

IV and/or oral antibiotics with local antibiotic loaded calcium sulfate beads

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with lower extremity osteoarticular infections with or without hardware

You may not qualify if:

  • patients who are hemodynamically unstable or have altered mental status and cannot give consent
  • patient per investigators discretion are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteomyelitis

Condition Hierarchy (Ancestors)

Bone Diseases, InfectiousInfectionsBone DiseasesMusculoskeletal Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization table will be prepared with treatment allocation specified in sealed envelopes. Participants are assigned a study number sequentially after consent is obtained. The surgeon and infectious disease specialist will develop a plan for IV and/or oral antibiotics based on culture results from the initial surgery. In addition, they will develop a plan for local antibiotics to be incorporated in the calcium sulfate beads. Antibiotics will actually be added only if the patient is assigned to the treatment group. The Investigator will then pull the envelope for the prospective study number and obtain the assigned treatment (antibiotic loaded beads versus sham beads). The calcium sulfate beads (with or without antibiotics will be placed during the second surgical procedure.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized, single blinded, prospective clinical trial where the treatment group will receive IV and/or oral antibiotics plus antibiotic impregnated beads, and the control group will receive IV and/or oral antibiotics plus calcium sulfate beads without antibiotics (sham beads). Systemic antibiotics therapy and the antibiotics contained in the antibiotic impregnated beads will be best available agents determined by the surgeon and infectious disease specialist.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 7, 2025

First Posted

July 18, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

July 18, 2025

Record last verified: 2025-07